DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Royalty Receipts grew 11% year over year to $672 million in Q2 2025 but missed analyst estimates by 0.15% (GAAP). Portfolio Receipts (non-GAAP) increased 20.0% year over year to $727 million, driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results